Newsroom

Share this article
News

GHIT 1st Anniversary Event – progress to date

10 July 2014

The 2014 decision by the Japanese Global Health Innovative Technology Fund (GHIT Fund) to support the Pediatric Praziquantel Consortium was a major...

Read more
Share this article
News

Preschoolers in Brazil

10 July 2014

Dr. Otávio Pieri is a researcher at the Oswaldo Cruz Foundation, with a research focus on schistosomiasis. He explains what is happening in Brazil, and the...

Read more
Share this article
News

ERC consolidator grant winner

10 July 2014

Prof. Jennifer Keiser of Swiss Tropical and Public Health Institute (Swiss TPH), partner at the Pediatric Praziquantel Consortium, received a prestigious ‘...

Read more
Share this article
News

Meet us at key conferences

09 July 2014

09-07-2014

The Pediatric Praziquantel Consortium partners are committed to enhancing awareness, and helping overall global efforts towards...

Read more
Share this article
Press release

Pediatric Praziquantel Consortium awarded US$1.86 million GHIT grant

28 March 2014

The Pediatric Praziquantel Consortium, launched in 2012 as an international non-profit public-private partnership, has announced that it has been awarded a...

Read more
Share this article
Press release

Pediatric Praziquantel Consortium expands into Brazil

25 March 2014

Goal is to make treatment for schistosomiasis accessible to children under six years of age in endemic countries.

Read more
Share this article
Press release

International partnership receives funding to develop a drug product to fight schistosomiasis (bilharzia) in children

22 August 2013

An international public-private partnership (PPP) was launched in July last year to develop a new pediatric formulation to combat schistosomiasis - commonly...

Read more
Share this article
Press release

New public-private partnership to develop a treatment for schistosomiasis-infected preschool children

02 July 2012

A newly established international public-private partnership (PPP) between TI Pharma, Merck KGaA (Darmstadt, Germany), Astellas Pharma Inc. and the Swiss...

Read more

Pages